The recent tragic deaths of
children due to encephalitis in Gorakhpur medical college have hit the
headlines in the last few days. These deaths also generated a lot of debate on
the issue. Unfortunately much of the debate centered on “finger pointing”. This
is not the time for a “blame game”.
This is not the first outbreak
of acute encephalitis syndrome (AES) in the region. Many such outbreaks have
been occurring for several years now and each epidemic has taken a heavy toll
of lives.
By now there should have been
a state of the art hospital to manage AES patients. There should have also been
a research facility to examine why the area is vulnerable to AES, establish
effective surveillance systems, plan a response plan, predict future outbreaks
etc.
This is the time to look to
the future and not talk of the past or even the present outbreak. Drawing from
the lessons of the past years, we must be able to anticipate such local
outbreaks and be ready to respond to them systematically and in a timely manner
to contain them. A research center focusing on AES will help to identify early
warning signals for such impending outbreaks.
Anticipation and preparedness
will enhance efforts to control and prevent future outbreaks of AES. All
stakeholders have equally important roles to play in prevention of any
epidemic.
Some key points on AES
·
Encephalitis is inflammation
of the brain parenchyma. It presents clinically as neurologic dysfunction
(altered mental status, behavior, or personality; motor or sensory deficits;
speech or movement disorders; seizure)
·
Viruses are the most commonly
identified infectious causes of encephalitis. Around 10% cases may be due to
Japanese encephalitis, scrub typhus and herpes simplex each. Enterovirus and
other viruses also cause AES. Bacteria, fungi, and parasites may also cause
encephalitis. In many cases of encephalitis, the etiology remains unknown
despite extensive evaluation.
·
The WHO’s guidelines for JE
surveillance recommend syndromic surveillance for JE meaning that all AES cases
should be reported (NVBDCP, 2009).
·
The NVBDCP 2009 guidelines on
management of AES have recommended classification of a suspected case as
follows:
o Laboratory-confirmed JE: A suspected case that has been
laboratory-confirmed as JE.
o Probable JE: A suspected case that occurs in close geographic and temporal
relationship to laboratory-confirmed case of JE, in the context of an outbreak.
o Acute encephalitis syndrome (due to agent other than JE): A suspected case
in which diagnostic testing is performed and an etiological agent other than JE
virus is identified.
o Acute encephalitis syndrome (due to unknown agent ) A suspected case in
which no diagnostic testing is performed or in which testing was performed but
no etiological agent was identified or in which the test results were
indeterminate.
·
The incidence is highest among
infants <1 year.
·
Status epilepticus, cerebral
edema, fluid and electrolyte disturbance, and cardiorespiratory failure are
some of the complications of AES.
·
ICU care is essential for
patients with severe encephalitis (i.e., those with seizures, cardiorespiratory
compromise, coma, or severe neurologic compromise) with close cardiorespiratory
monitoring and careful attention to neurologic status, fluid balance, and
electrolyte status.
·
Prognosis of viral
encephalitis depends upon the age of the patient, neurologic findings at the
time of presentation and the etiopathogen.
·
The case fatality and
morbidity is very high among various viral encephalitis especially in JE or
enterovirus encephalitis.
·
Survivors of childhood
encephalitis should be monitored for long-term sequelae.
·
Scrub typhus encephalitis: Curable
with doxycycline or erythromycin if diagnosed early. Look for fever, rash,
local black eschar in the legs with enlarged, lymph nodes.
·
Japanese
encephalitis: Mortality is 20% in the best of the centers. Preventable by
vaccination.
·
Herpes simplex
encephalitis: Can be diagnosed due to temporal lobe localization and can
be managed with antivirals.
·
Lichi encephalitis is
manageable with intravenous glucose.
·
Enteroviral encephalitis has
limited therapeutic options. Intravenous immunoglobulin (IVIG) is often
administered despite a lack of convincing evidence for efficacy.
·
All children who present with
suspected encephalitis should be treated with acyclovir pending viral studies.
·
Empiric treatment for
bacterial meningitis pending bacterial cultures also may be warranted if
bacterial meningitis cannot be excluded.
·
Empiric treatment with
doxycycline or erythromycin should be given till scrub typhus is ruled out.
·
Prevention strategies include
hand hygiene, appropriate management of pregnant women with active herpes
simplex virus lesions, routine childhood immunizations, JE vaccine, traveling
immunizations, and insect control and avoidance measures. Control of culex mosquito.
·
All children who are
hospitalized with encephalitis should be placed on airborne, droplet, and
contact precautions at the time of admission, pending identification of a
pathogen.
Dr KK Aggarwal
No comments:
Post a Comment